Matthew Callstrom, M.D., Ph.D. (VIEW BIO)
Dr. Klevos is fellowship trained in both Breast Imaging and Interventional Radiology. She completed her Radiology residency and fellowships at the University of Miami. Upon the completion of her training, she served in an academic capacity as a faculty member at the University of Miami in Breast Imaging and as the Chief of Breast Interventional Oncology. She is double board certified by the American College of Radiology in Diagnostic Radiology and by the American Board of Internal Medicine.
She has authored and co-authored several peer reviewed journal articles in the fields of both Breast Imaging and Interventional Radiology. She is recognized for her published works in Image Guided Cryoablation of Breast Tumors, Breast Cancer, Treatment of metastatic colorectal cancer with DEBIRI and Irreversible electroporation (IRE) for pancreatic cancer. She is a graduate of the founding class of the PLA (Physician Leadership Academy-South Florida chapter) and has published articles on important topics like Physician Burnout and the ‘Business of Medicine’. Additionally, she has been an invited speaker in multiple national and international medical conferences in the fields of Breast Imaging and Interventional Radiology.
Her current research interest and passion is focused in the field of Breast Cancer and finding minimally invasive treatments to cure breast cancer including Cryoablation.
Assistant Professor of Radiology at Northwestern University Feinberg School of Medicine Chicago, IL
As an interventional radiologist, I use image guidance (x-rays, ultrasound, CT, PET, or MRI) to perform minimally invasive procedures. The images are used to direct tiny catheters, wires, and needles in order to diagnose and treat tumors. Using image guidance allows us to perform a wide variety of procedures without making large incisions, leading to shorter recovery times and fewer complications. We can also treat tumors by burning or freezing them (ablation) or clogging the arteries that supply them with different materials (embolization). Other procedures we perform include biopsies, opening an obstructed channel (for example, a vessel, a bile duct, or a ureter), or stopping a bleeding vessel.
I am also trained as a computational biologist, which means I develop, adapt, and apply algorithms from machine learning and information theory to biology. Some of my previous work focused on building mathematical models of biological networks such as gene networks and structural brain networks. Currently I am working on applying these same tools to analyzing genomic data from tumors to better predict and ultimately better tailor treatments to individual patients.
Dr. Bradford Wood directs a multi-disciplinary team (NIH Center for Interventional Oncology) that develops and translates devices, software, and navigation approaches for cancer patients via novel local and regional minimally-invasive image-guided therapies. Dr. Wood has directed the Interventional Radiology Research Lab from 2004 to present, and was Acting Co-Director of Radiology from 2006 to 2008. His research relies upon multi-disciplinary team science within multiple institutes and holds appointment in Radiology & Imaging Sciences in the CC, as well as the Urological Oncology Branch in NCI/CCR. He has received both the Clinical Center Director’s Award and the NIH Director’s Award, and has published widely in the field of Interventional Radiology and the emerging discipline in Interventional Oncology. The Center for Interventional Oncology translates technologies and paradigms for first in human treatments for cancer and cultivates interventional radiology applications within a muliti-disciplinary framework, to apply biomedical engineering to solve real-life clinical problems and patient care needs. His team’s achievements include helping to pioneer several technologies from concept to bench to patient, including prostate cancer MRI/TRUS fusion biopsy and ablation, image-able iodinated drug eluting beads for chemoembolization of liver tumors, heat deployed chemotherapy combined with thermal ablation for liver cancer, “medical GPS” electromagnetic (EM) tracking for fusion of ultrasound to CT, MR, and PET, and fusion for needle-based procedures like biopsy and thermal ablation, and other smart needles, devices, and software for minimally invasive, multi-modality, image-guided procedures. Dr. Wood &/or the CIO team performed “First-in-human” treatments including: First RFA for kidney tumors; First RFA of pheochromocytoma, adrenocortical carcinoma, & chordoma; First thermal ablation of liver tumors augmented with heat-deployed liposomal doxorubicin; First iodinated & image-able drug eluting bead embolization of liver tumors; First GPS-enabled ablation and biopsy devices; Ultrasound fusion enabled navigation systems; and PET, MRI, CT and ultrasound fusion interventions.
Clinical Interest for Patients I take care of patients with all kinds of bone and soft tissue tumors and cancers, including sarcomas, desmoid tumors, GIST, and PVNS (tenosynovial giant cell tumor). I an an expert not only in standard chemotherapy treatments, but also am active in clinical trials including immunotherapy, and personalized/precision medicine. Care Philosophy I believe that medicine, especially cancer medicine, is best practiced as a partnership between doctors, researchers, and patients. Decisions are always best made as a team effort, taking into account every aspect of a patient’s unique situation! Personal Interests I have recently moved from Miami, Florida to Denver and had to change my hobbies a bit! My husband and I love fishing and boating, and now are getting into exploring the incredible outdoor activities, including hiking, off-roading in our Jeep, learning to ski, and just being outside with our dog! Volunteer Activities I am active with several patient-initiated foundations as an advisory board member, helping to empower patients, families and advocates to advance research to find a cure for sarcomas. Public Speaking Yes I enjoy speaking to patients, families, and physicians in the community to raise awareness of sarcomas and to provide updates on new research including immunotherapy.
Interventional Radiologist at Minimally Invasive Procedure Specialists. Parker, Colorado Specializing in Liver Directed Therapy and Prostate Embolization. Personally performed over 1500 radioembolizations and 150 PAE’s.
Interventional radiologist with interventional oncology as special field of expertise. Head fellowship and differentiation program interventional radiology for (resident) radiologists. Certified senior investigator interventional radiology and oncology trial reader. Primary investigator of several multicenter controlled studies in the field of thermal and non-thermal ablation and trans-arterial therapies for malignancies within the liver, pancreas and biliary tract. Expert in open and percutaneous minimally invasive image guided treatments such as radiofrequency ablation, microwave ablation, irreversible electroporation (nanoknife), transarterial bland embolization, chemo- and Y90 radioembolization. General expertise in treatment of vascular interventions such as acute traumatic and non-traumatic hemorrhages, peripheral arterial disease (PTA and stenting), venous interventions and non-vascular interventions such as percutaneous transhepatic cholangiography, abscess drainage, ultrasound and CT guided biopsy and percutaneous nephrostomy
Minesh P. Mehta, M.D. Medical School: University of Zambia, Zambia Post Graduate: Ndola Central Hospital, Zambia Radiation Oncology, University of Wisconsin Board Certifications: American Board of Radiology; United Council for Neurologic Subspecialties
Dr. McWilliams obtained his Bachelor of Science in Biology at Truman State University in Missouri, where he graduated valedictorian and Summa Cum Laude. He then attended the David Geffen School of Medicine at UCLA, where he received multiple letters of distinction and was selected for the Alpha Omega Alpha National Medical Honor Society. After completing a transitional internship at St. Vincent’s Hospital in New York City, Dr. McWilliams returned to UCLA for radiology residency. There he served as Chief Resident, and also received awards for Outstanding Radiology Resident and Outstanding Graduating Senior Resident. He then remained at UCLA for interventional radiology fellowship, at which time he also served as Chief Fellow. Upon completion of his fellowship, Dr. McWilliams accepted a faculty position in the interventional radiology department at UCLA. There he splits his time between angio/interventional procedures and cross-sectional interventional procedures, with a focus on HHT, interventional oncology, prostate embolization, vascular disease, dialysis work, and liver interventions.
Dr. M. Manoharan MD, FRCS(Eng), FRACS(Urol) is the Professor and Chief of Urologic Oncology and the Director of Robotic Urologic Surgery at the Miami Cancer Institute, Baptist Health South Florida, Miami, USA . He is internationally known for his expertise in Urologic Oncology, Robotic surgery and other complex and minimally invasive urologic cancer surgery . He has served a member in the International bladder cancer guidelines committee. He has delivered several lectures in both national and international scientific meetings and conducted urological workshops. He has published more than 140 articles in peer reviewed journals and authored 15 text book chapters. He is an active investigator in several Urologic Oncology research studies. He completed his urology training in New Zealand and Urologic Oncology training at University of Miami.
Dr. David C. Madoff is Vice Chair for Academic Affairs and Professor of Radiology at Weill Cornell Medicinein NYC. Dr. Madoff earned his B.A. from Emory University and his M.D. from the University of Pittsburgh. He completed his internship in Internal Medicine and residency in Diagnostic Radiology at SUNY at Stony Brook. His fellowship training in IR was at MD Anderson Cancer Center. He was on faculty at MD Anderson Cancer Center for a decade before joining Weill Cornell in 2011. From January 2011 to November 2015, Dr. Madoff served as IR Division Chief. Dr. Madoff has a strong background in clinical care and has treated many patients with complex oncological problems. He is world-renowned for his work on preoperative portal vein embolization, a technique based on the liver’s ability to regenerate that has been used in patients with hepatobiliary cancer to increase the size of the anticipated liver remnant before surgery. Without this procedure, many patients with potentially resectable disease would not be eligible for curative resection. Dr. Madoff is a leader in academic IR and an invited speaker at numerous national and international meetings. He authored over 120 peer-reviewed articles, written more than 30 book chapters and served as co-editor of four textbooks. Dr. Madoff served as Deputy Editor for RADIOLOGY from 2012-2017 and Deputy Editor-in-Chief of JVIR from 2007-2010. Dr. Madoff currently serves on the editorial boards of Techniques in Vascular and Interventional Radiology, Seminars in Interventional Radiology, Cancer Biology & Medicine and European Radiology Experimental. Dr. Madoff is active in many major radiological societies including RSNA, ARRS, SIR and AUR and serves on the Board of Trustees of the ARRT. Based on his important contributions to the field, Dr. Madoff was elected Fellow of SIR in 2007, ACR in 2015 and CIRSE in 2017.
Robert John Lewandowski, MD is the Director of Interventional Oncology at Northwestern Memorial Hospital in Chicago, Illinois. He specializes in minimally invasive image-guided cancer therapies for primary and secondary hepatic malignancies.
Transplant Center at Carolinas Medical Center
1000 Blythe Blvd.
Charlotte, NC 28203
Get Directions | View Map
Jackson Memorial Hospital
Completion Year: 1999
Medical School or Graduate School
University of Miami School of Medicine
Completion Year: 1992
Specialty: General Surgery
Completion Year: 1997
American Board of Surgery
Fred T. Lee Jr, MD is a Professor of Radiology, Biomedical Engineering, and Urology, The Robert A. Turrel Professor of Imaging Science, and the Chief of Abdominal Intervention at the University of Wisconsin. Previous roles include Chief of Abdominal Imaging and Intervention and Senior Vice Chair at the University of Wisconsin Department of Radiology. He has been a University of Wisconsin faculty member since 1991, and was designated as a Radiologic Society of North America Scholar in 1996. Dr. Lee established the Tumor Ablation Laboratory at the University of Wisconsin in 1995, one of the first of its type in the world. His work has resulted in over 200 scientific publications, hundreds of scientific and business presentations, 20 book chapters, 24 inventions/patents, and substantial federal and industrial grant support. He is the recipient of more than 50 major honors and awards including multiple “Best Doctor” awards, the UW Health Presidential Physician Leadership Award, and the Grand Prize in the 2014 Wisconsin Governor’s Business Plan Competition. Dr. Lee is a founding member of the International Working Group on Tumor Ablation, and a founder of three venture-backed biotech start-up companies devoted to cancer treatment: Cellectar, Inc. (Madison, WI), NeuWave Medical Inc. (Madison, WI a member of the Ethicon and Johnson & Johnson family of companies), and Elucent Medical, Inc. (Minneapolis, MN). NeuWave Medical was sold to Ethicon (Johnson & Johnson) in May 2016, and Dr. Lee remains as a consultant. Dr. Lee currently serves on the board of directors and as Senior Medical Advisor for Histosonics, Inc., a University of Michigan startup company developing a non-invasive, non-thermal focused ultrasound technology for tissue destruction, and is a founder and board member of LiteRay LLC, a company developing methods to reduce radiation dose to physicians and patients during percutaneous interventions.
Rupesh Kotecha, M.D., is a board-certified radiation oncologist at Miami Cancer Institute. Dr. Kotecha is the Chief of Radiosurgery and has specialized training and experience in utilizing the latest techniques in radiation therapy treatment for both cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiotherapy, including CyberKnife®, LINAC-based and GammaKnife® radiosurgery, and stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR). He also specializes in advanced radiation therapy treatment techniques, including re-irradiation, proton beam radiotherapy, and MR-guided radiation therapy. He also has unique expertise in cardiac radiosurgery, an emerging non-invasive procedure for patients with cardiac arrhythmias. During medical school, Dr. Kotecha was inducted into the Alpha Omega Alpha Honor Medical Society, an organization that recognizes excellence in scholarship and the profession of medicine. He has been an invited speaker at numerous national and international symposiums, and has published multiple book chapters and dozens of articles in peer-reviewed journals, including the Journal of Clinical Oncology, International Journal of Radiation Oncology Biology Physics, Cancer, and Practical Radiation Oncology. He is an editorial contributor on the topic of brain cancer for Practice Update, an online resource for healthcare providers throughout the United States and around the world.
Maureen Kohi, M.D.
Chief, Interventional Radiology and Biomedical Imaging
505 Parnassus Ave., Room M-361
San Francisco, CA 94143
Phone: (415) 353-1300
Appointments: (415) 353-2573
Billing: (415) 514-8888
Fax: (415) 353-8570
Hours: Monday to Friday
8:30 a.m. – 5 p.m.
Radiology at Divisadero Street
1600 Divisadero St., Room A-142 and A-219
San Francisco, CA 94115
Scheduling: (415) 353-2573
CT, MRI and Bone Densitometry: (415) 885-7282
X-Ray and Nuclear Medicine:
Fax: (415) 353-7299
8 a.m. – 5 p.m.
Diagnostic Radiology, American Board of Radiology
More about Maureen Kohi
New York School of Medicine 2005
UCSF Medical Center 2010
UCSF Medical Center 2012
Selected Research and Publications
Seo Y, Khalighi MM, Wangerin KA, Deller TW, Wang YH, Jivan S, Kohi MP, Aggarwal R, Flavell RR, Behr SC, Evans MJ. Quantitative and Qualitative Improvement of Low-Count [68Ga]Citrate and [90Y]Microspheres PET Image Reconstructions Using Block Sequential Regularized Expectation Maximization Algorithm. Mol Imaging Biol. 2019 Apr 15.
Wang M, Ballah D, Wade A, Taylor AG, Rizzuto G, Li B, Lucero J, Chen LM, Kohi MP. Uterine Artery Embolization Following Cesarean Delivery but Prior to Hysterectomy in the Management of Patients with Invasive Placenta. J Vasc Interv Radiol. 2019 Mar 25.
Wang M, Laguna B, Koethe Y, Lehrman E, Kumar V, Kohi MP. Bridging the Gender Gap in the Society of IR: A Benchmark Study. J Vasc Interv Radiol. 2019 Feb 27.
Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.
Dr. Kim is an Associate Professor of Radiology at Georgetown University Medical Center where he serves as the Chief of the Division of Interventional Radiology. After receiving his medical training from Drexel University College of Medicine, Dr. Kim completed a surgical internship at Medstar Georgetown University Hospital. He went on to perform a research fellowship at Memorial Sloan Kettering Cancer Center where he studied various molecular pathways involved in cancer development. He performed his post-graduate training in radiology at Medstar Georgetown University Hospital where he also completed his fellowship in Vascular and Interventional Radiology. His main clinical and research interest is in interventional oncology – specifically to develop methods to augment outcomes from liver-directed therapies – and has published a number of papers on this topic. He currently serves as an investigator in a number of single center and multi-center trials in various interventional oncology treatments.
Matthew S Johnson, MD FSIR is Professor of Radiology and Surgery, Gary J Becker Professor of Radiology Research, and Director of Clinical Research in the Department of Radiology and Imaging Sciences, and Director of Interventional Oncology for Indiana University Health. He is the Secretary of the Society of Interventional Radiology and and Co-Primary Investigator of the PRESERVE study, which is evaluating the safety and efficacy of IVC filters in the United States. More than 1400 subjects have been enrolled in that multi-institutional trial since its initiation October, 2015.
Dr. Geronemus received his undergraduate degree from Indiana University and his medical degree from the University of South Florida College of Medicine in Tampa, Florida. He completed a residency in diagnostic radiology at the University of South Florida College of Medicine, as well as a fellowship in interventional radiology at Miami Cardiac & Vascular Institute.
Dr. Geronemus is Board-Certified in Diagnostic Radiology with a Certificate of Added Qualification in vascular and interventional radiology.
Dr. Christopher Gomez is a specialist in urinary incontinence and urogenital reconstruction. He earned his medical degree and completed a residency in urology at the University of Miami where he was recognized for his accomplishments in urologic research. He went on to complete a fellowship in female urology, urodynamics and reconstruction. He returned to the University of Miami in 2011 at which point he became a faculty member with the urology department, and in 2012, he became the associate program director of the urology residency program. In 2018 he joined the Miami Cancer Institute to start a center for Continence and Genitourinary Reconstruction. Dr. Gomez was awarded the American Urological Associate/Urologic Society of India academic exchange scholar grant where he focused on urogenital reconstruction in India. He was also selected by the Society of Genitourinary Reconstructive Surgeons and American Urological Society to participate in urethral reconstruction and vesicovaginal fistula repairs in Haiti. He continues to lecture nationally and internationally regarding the impact of neurologic disease on the urinary system and urogenital reconstruction. Dr. Gomez is currently working to advance urologic medicine using minimally invasive surgical techniques to treat benign prostatic hyperplasia, pelvic organ prolapse and urinary incontinence, and he is actively involved in research to test and develop new treatments for these disorders.
El Dr. Ricardo García Mónaco es un destacado Radiólogo Intervencionista, especialista en Terapia Endovascular y Angiografía, de reconocimiento nacional e internacional.
Realizó sus estudios médicos en la Universidad de Buenos Aires, en donde se doctoró con Diploma de Honor en el año 1981. Luego completó su residencia en el Hospital Italiano de Buenos Aires y su Fellowship en Angiografía y Radiología Intervencionista en el Bicetre Hospital de París, Francia. También realizó un Fellowship en Neuroradiología Intervencionista en el New York Medical Center, Estados Unidos, un Fellowship en Neuroradiología en el Toronto Western Hospital, Canada, y un Fellowship en Intervencionismo Oncológico en el Instituto Gustave Roussy, Francia.
Actualmente se desempeña como Jefe del Servicio de Diagnóstico por Imágenes del Hospital Italiano, así como Jefe de la Sección de Angiografía y Terapia Endovascular. Se desempeñó durante dos mandatos consecutivos como Presidente de la Sociedad Argentina de Radiología, en el período 2001-2006, y es actualmente Miembro Honorario Nacional de dicha Sociedad. Asimismo, fue Presidente del Colegio Interamericano de Radiología (CIR) durante el período 2006-2008, y es también Profesor Titular en la Especialidad de Diagnóstico por Imágenes de la Facultad de Medicina de la Universidad de Buenos Aires.
Miembro de numerosas organizaciones profesionales, entre ellas:
RSNA (Radiological Society of North America)
SCVIR (Society of Interventional Radiology)
CIRSE (Cardiovascular and Interventional Radiological Society of Europe)
CIR (Colegio Interamericano de Radiología).
ISR (International Society of Radiology).
ISSSR (International Society for Strategic Studies in Radiology).
ISSVA (International Society for the Study of Vascular Anomalies)
En 2005 se convirtió en el primer médico de Sudamérica en recibir la Membresía Honoraria de la Sociedad Europea de Radiología (ESR), galardón que recibió también en el año 2002 de parte de la Sociedad Italiana (SIRM), y en 2009 de la Sociedad Francesa de Radiología (SFR). Entre 2006 y 2010 fue miembro del International Advisory Committee (IAC) de la Radiological Society of North America (RSNA), siendo el primer médico argentino en ocupar un cargo similar. Se desempeña también como Reviewer de importantes publicaciones médicas, como por ejemplo la revista Radiology (RSNA) y JVIR (SIR).
La Sociedad Argentina de Radiología le otorgó en 2010 la Medalla Dorada a la Trayectoria en Radiología, y en 2011 recibió la Membresía Honoraria de la Radiological Society of North America (RSNA), siendo la primera vez que esta sociedad otorga semejante reconocimiento a un radiólogo argentino en sus 92 años de historia.
El Dr. García Mónaco ha realizado hasta el momento alrededor de 412 presentaciones de trabajos científicos en Congresos tanto nacionales como internacionales, y ha publicado cerca de 172 trabajos e investigaciones en revistas y libros especializados, muchos de los cuales han recibido premios y distinciones.
Afshin Gangi, M.D., Hospital of Strasbourg, Strasbourg, France Dr. Afshin Gangi received his education in the International French School of Teheran, graduating in 1980. During the summer of 1980, he attended medical school at the University of Reims in France, receiving his Degree in 1987. He began his residency in Strasbourg in 1987, first in the intensive care unit and Pneumology where he became excited about imaging and moved to the imaging department. After his Residency in general radiology and Neuroradiology, he worked one year in Luxembourg with Professor R.F. Dondelinger in Interventional Radiology. Dr. Gangi began his fellowship in Strasbourg in November 1991 in the department of Neuroradiology and MSK with special interest in percutaneous procedures. He performed his first vertebroplasty in 1989 during his residency and continued to develop image-guided procedures in interventional oncology, especially under CT-C arm fluoroscopy and MR guidance. In 1995, Dr. Gangi obtained his Ph.D. in Laser Physics in Strasbourg. During the same year, he was appointed Assistant Professor in the University Hospital of Strasbourg and he became a full Professor of Radiology in 2000. Since 2014, he is working in King’s college London for research in interventional oncology and HIFU as an invited Professor with Professor Andy Adam. Prof Gangi holds numerous patents and is an author of more that 200 peer reviewed articles. He has more than 35 book chapters to his credit along with over 500 abstracts at numerous national and international conferences. Currently, Dr. Gangi is the Chairman of Radiology and Nuclear medicine in the University Hospital and work in the department of Interventional Radiology, with a special interest in Interventional Oncology. He is actively involved in different international society and is the vice president of Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Ripal T. Gandhi, M.D. is faculty at Miami Cardiac & Vascular Institute / Miami Vascular Specialists and Miami Cancer Institute. He is also an associate professor at FIU Herbert Wertheim College of Medicine and USF College of Medicine. Dr. Gandhi graduated summa cum laude from Northwestern University with a degree in Biology. He received his medical degree from Northwestern University Feinberg School of Medicine. Following medical school, he completed a surgical internship at Cornell University Medical Center and New York Presbyterian Hospital. He completed his residency training and fellowship at UCLA Medical Center and was voluntary faculty at UCLA following fellowship. He has served as a research fellow at the National Institutes of Health and dedicated an entire year to biomedical research at the renowned Memorial Sloan-Kettering Cancer Center in New York. Prior to joining Miami Cardiac & Vascular Institute, Dr. Gandhi was an international visiting scholar at Asan Medical Center/University of Ulsan Medical School in Seoul, South Korea. He has authored multiple scientific papers, presented research findings at national and international meetings, and is the recipient of multiple awards. He has published a textbook entitled “Interventional Oncology”. Hs also a course director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).
Chiara Floridi, MD San paolo University Hospital Milano Born 05.05.1982 M.D., Univeristy of Perugia (110/110 cum laude), 2007 MEDICAL TRAINING Residency in Diagnostic and Interventional Radiology, University of Perugia , 2008-2012 Fellowship in Interventional Radiology Univerity of Insubria-Varese, 2012-2013 PROFESSIONAL EXPERIENCES Physician Consultant at Diagnostic and Interventional Radiology Varese Hospital (2013-2016) Physician Consultant at Diagnostic and Interventional Radiology san Paolo University Hospital, Milano (2016-Present)
Mehul Harshad Doshi, MD, is an Interventional Radiologist at Cleveland Clinic Florida, Weston, and a Clinical Affiliate Associate Professor of Radiology at Charles E. Schmidt College of Medicine – Florida Atlantic University. Dr. Doshi completed his medical school and residency in Radiology from B. J. Medical College, civil hospital, Ahmedabad (India) in 2004. He subsequently completed fellowships in Vascular Interventional Radiology and Neuroradiology from Jackson Memorial Hospital/ University of Miami in 2008. He served as a faculty in the Department of Radiology and Interventional Radiology at the University of Miami from 2008 to 2018. In April 2018, Dr. Doshi joined the section of Interventional Radiology at Cleveland Clinic Florida. Dr. Doshi is Board-Certified in Diagnostic radiology with a Certificate of Added Qualification in Vascular and Interventional Radiology from the American Board of Radiology (ABR). He is a member of the Society of Interventional Radiology (SIR). Dr. Doshi’s areas of clinical interest include Interventional Oncology, TIPS and management of portal hypertension, embolization and ICV filters. His research interests include tissue ablation, chemoembolization, portal hypertension and IVC filters.
Dr. Thierry Jacques de BAERE 20 juillet 1962 French Head of department of intreventional radiology Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France – Tel : 00 33 142115428 Main interests : Tumor ablation Portal vein embolization Intra-arterial therapies Digestive tract intervention Chairman of standard of practice committee at CIRSE 2007-2009 Member of the scientific committee of WCIO 2006-2008/2011, ECIO 2008/2010, CIRSE 2008/2009, GUEST 2008-2011, ECR 2013 Chairmann of the proram committee ECIO 2012/2013 Memeber of the CIRSE Foundation Advisory Council 2008-2012 Reviewer JVIR, CVIR, Radiology, European Radiology Full time dedicated to interventional oncology at Institut Gustave Roussy since 1991. Clinical work dedicated to minimal invasive therapy for treatment of liver, lung and kidney tumors. Treatment of liver tumor is optimized due to excellent collaboration with surgery and medical oncology teams, namely through devellopement of many synergistic treatment, including optimization of various intra-arterial therapies for primary and secondary liver tumors. We have been working since over 15 years in the field of percutaneous ablation of liver tumors either by direct injection, or more recently physical destruction . Our first RF experience was in 1996. We are also investigated pre-operative portal vein embolization in order to hypertrophy unembolized parts of the liver. These treatments have been develloped from experimental studies in order to allow a rapid transfer from bench-top to clinical applications.
Michael Darcy, M.D., Professor of Radiology at Washington University in St. Louis Chief, Interventional Radiology at Barnes Jewish Hospital and the Mallinckrodt Institute of Radiology
Dania Cioni MD Assistant Professor of Radiology at Department of Radiology, Univerity of Pisa Clinical and research activities on diffuse and focal liver lesions buy using contrast ultrasound, computed tomograpy and magnetic resonace imaging, and on interventional oncology procedures and new molecular-targed drug for the treatment of liver malignancies
Jacob Cynamon, MD, Director of Vascular and Interventional Radiology at Montefiore Medical Center and Prof of Radiology at Albert Einstein College of Medicine. Chairman of the AIMsymposium, an annual vascular and interventional radiology symposium held in November in NYC. Currently planning the 27 th year. Research in Dialysis access, Arterial and venous thrombolysis. PI for the Safeflow IVC filter. Seatlle 2 investigator. Recently described a new technique for transvenous liver biopsies- TransFemoral TransCaval (TFTC) liver biopsies One of the team that performed the first Aortic Stent Graft procedure in the US. Current practice is concentrated on interventional oncology, Venous Disease, Women’s health, and Prostate Artery Embolization for BPH.
Undergraduate: University of Miami, School of Engineering Medical School: University of Miami, School of Medicine Residency: Emory University Affiliated Hospitals Fellowship: Cardiovascular and Interventional Radiology at Hospital University Pennsylvania and Children’s Hospital of Philadelphia Board Certification: American Board of Radiology Societies: Radiological Society of North America, Society of Interventional Radiology Specialties: Interventional Radiology with CAQ Dr. Cohn joined Radiology Associates of Hollywood in 1999 after completing his fellowship training from the Hospital at University of Pennsylvania and Children’s Hospital of Philadelphia. His particular area of expertise is in interventional oncology services. Dr. Cohn has pioneered and is responsible for bringing various new interventional oncological procedures to Memorial and south Florida such as: Hepatic Arterial Chemoembolization, Radio-embolization and Radio Frequency/Microwave/Cryo Ablation for oncology patients. He is highly experienced and trains other physicians throughout the U.S.in interventional oncological intervention such as radio-embolization. Dr. Cohn frequently travels as an invited lecturer throughout the United States and has also published several articles. He now serves as Co-Director of Interventional Radiology at the Memorial Healthcare System, Broward County Florida and is an assistant Professor at the Florida Atlantic University Medical School.
Dr. Michael Chuong, MD is a radiation oncologist and director of radiation oncology clinical research at Miami Cancer Institute. He is a member of the NRG Oncology GI committee and the Disease Site Committee Chair for the Proton Collaborative Group. His clinical practice focuses on gastrointestinal cancers for which he has expertise in treating with IMRT, MR-guided SBRT, and proton therapy. He has published numerous peer reviewed manuscripts and is actively involved in clinical trials development.
Dr. Chapiro joined the Department of Radiology and Biomedical Imaging as a research scientist and interventional radiology resident from Berlin, Germany. After graduating from the University of Leipzig and upon completion of his research thesis at the Justus-Liebig University in Giessen, he served as a postdoctoral fellow in interventional oncology at The Johns Hopkins Hospital and then as radiology resident at the Department of Radiology, Charité University Hospital in Berlin. Dr. Chapiro works on the development of novel imaging biomarkers, tumor response criteria, staging systems and molecular imaging techniques for image-guided liver cancer therapies. His translational research portfolio includes the development of novel embolic agents as well as the application of artificial intelligence and machine learning solutions for the assessment of liver cancer. His basic research interest mainly focuses on tumor metabolism and immuno-oncology. With over 50 peer-reviewed publications, book chapters and news articles, Dr. Chapiro advocates the element of personalized medicine in interventional oncology, which is the most rapidly growing field in interventional radiology practice. Creating innovative and clinically practicable solutions and translating them from concept to practice has been his central mission for the past five years. He is the co-initiator of the “Rising Star” Student Exchange Program in collaboration with the Charité University Hospital in Berlin and co-directs the Yale Radiology Research laboratory.
Dr. Jorge Raul Caso is an adjunct assistant professor of urology at FIU and the director of the urologic oncology fellowship and of the kidney cancer institute at the Miami Cancer Institute at Baptist Health. He has lectured in national and international conferences on advanced laparoscopic and robotic surgery for genitourinary malignancies. Dr. Caso has extensive experience in kidney surgery, including the utilization of laparoscopic single site and robotic platforms for nephrectomy and partial nephrectomy. He has particular interest in extraperitoneal and retroperitoneal approaches to renal and pelvic surgery, bypassing intraabdominal approaches where precluded by medical history. He is an expert in performing robotic radical prostatectomy and complex upper and lower tract reconstruction by minimally invasive means. Dr. Caso has published extensively in the surgery and natural history of varied malignancies. His interests include outcomes based-research and novel surgical techniques.
Theresa Caridi, M.D., is an assistant professor in the Division of Vascular and Interventional Radiology at MedStar Georgetown University Hospital in Washington, D.C. After attending the University of Florida for medical school and radiology residency, Dr. Caridi completed a fellowship in vascular and interventional radiology at the University of Pennsylvania. She then joined the faculty at Georgetown. Dr. Caridi is board certified in radiology and also holds her specialty certification for interventional radiology. She currently serves as the medical student clerkship director for interventional radiology at MedStar Georgetown University Hospital. Dr. Caridi is an active member of the Society of Interventional Radiology (SIR) and is presently serving as an officer on the SIR Foundation Board of Directors as the Development Division Chair. She has been named a Washingtonian Top Doctor in 2018, an honor given to her as a preeminent physician in the DC, Maryland and Virginia region. Special interests include the treatment of uterine fibroids and other uterine conditions, pelvic venous congestion/ varicocele, prostate hypertrophy, and pulmonary AVMs.
Jim Caridi MD FSIR, Professor of Vascular and Interventional Radiology and Chairman of Radilogy at Tulane University Medical School. Initial training began at FSU and UF in Florida where he was chief of vascular and interventional radiology for 20 years. Part of this time he also served as fellowship program director. During his tenure along with Dr. I Hawkins and staff they published many peer reviewed articles as well as book chapters and posters. Many of the educational materials centered around improving safety and techniques for vascular and interventional procedures as well being the thought leaders for the use of CO2 as an alternative contrast agent. In 2013 Jim moved to Tulane University Medical Center where he started as an attending in VIR. He has since become Chairman of the Department of Radiology.
Dr. Callstrom is a Professor of Radiology and Vice Chair for the Department of Radiology at Mayo Clinic in Rochester. He serves as the Director of the Ultrasound Research Center. His clinical and research foci are on image-guided intervention to treat cancer. In particular, Dr. Callstrom is an expert in the use of various ablation technologies for treating neoplasms in liver, lung, kidney, bone, and soft tissue. Research efforts include developing an understanding of the response of neoplastic cells to thermal injury, development of new imaging methods for improved tumor targeting, and involvement in clinical trials to understand efficacy of interventional oncologic treatments. Dr. Callstrom has a strong track record of collaborating with academic and industrial investigators. His involvement in education is mentoring Ph.D. students in experimental design and laboratory studies, as well as mentoring radiology residents and fellows in the medical graduate program. Dr. Callstrom has previously mentored 4 Ph.D. students.
James F. Benenati, MD, FSIR, is a practicing Interventional Radiologist, Medical Director, Noninvasive Vascular Laboratory and Fellowship Program Director at the Miami Cardiac & Vascular Institute at Baptist Hospital in Miami, Florida.
He is a Clinical Professor of Radiology at Florida International University College of Medicine and Associate Professor of Radiology at the University of South Florida College of Medicine. He is past President of SIR. He served as President of the Vascular Division for the Intersocietal Accreditation Committee (IAC) and served for over a decade on their board. He served as the annual meeting chairman for SIR in 2005. He was the recipient of the SIR Charles T. Dotter Award in 2014.
He has participated in numerous clinical research projects and national trials. His interest include peripheral arterial disease, abdominal aortic aneurysm and management of pulmonary embolism. He has authored and co-authored more than 100 scientific publications. He has been a Program Director of ISET for over 20 years.
He attended the University of Notre Dame as an undergraduate, received his medical degree from the University of South Florida College of Medicine, completed a residency in Diagnostic Radiology at Indiana University and a fellowship at Johns Hopkins.
Yolanda Bryce, MD, RPVI, Assistant Attending in Memorial Sloan Kettering Cancer Center, with special interests in minimally invasive locoregional treatment of primary breast cancer as well diagnosis and treatment of vascular disorders in the oncologic patient.
Dr. Daniel Brown is a radiologist in Nashville, Tennessee. He received his medical degree from Drexel University College of Medicine and has been in practice for more than 20 years.
Dr. Sandeep Bagla is board certified in Diagnostic Radiology with a Certificate of Added Qualification in Interventional Radiology. He graduated with honors from St. Georges University School of Medicine before completing residency in Diagnostic Radiology at Albany Medical Center where he also served as Chief Resident. Dr. Bagla completed subspecialty training in Vascular & Interventional Radiology at George Washington and completed his Certificate of Added Qualification (CAQ) in Vascular & Interventional Radiology. He has been selected as a Top Doctor in multiple publications, including Washingtonian Magazine. Dr. Bagla is actively involved in clinical research, leading multiple clinical trials and receiving national grant awards. His research interests have included: Prostate Artery Embolization in the Treatment of Benign Prostate Hypertrophy, Soft Tissue Tumor Ablation, Pancreatic Cancer and Pulmonary embolism. He has delivered invited lectures at numerous scientific meetings both nationally and abroad. Dr. Bagla has numerous publications in peer- reviewed journals and currently reviews manuscripts for publication in two major medical journals: Journal of Vascular & Interventional Radiology and Cardiovascular & Interventional Radiology. He has co-authored book chapters on Prostate Artery Embolization and has delivered numerous invited lectures at national and international meetings. Dr. Bagla currently sits on the physician advisory board of multiple worldwide medical device companies providing his advice for the future of cancer and robotic therapy.
Bulent Arslan, MD, is trained for his fellowship at University of Rochester, New York. His first job was at Tucson Veterans Hospital, where he developed a vascular intervention consult service and provided system wide education for management peripheral vascular disorders. Performed first carotid stenting and percutaneous thoracic aneurysm repair in the VA Healthcare system. Received several gold star awards for outstanding service. He then moved to University of Virginia where he performed several first in man procedures, such as in-vivo fenestration of a stent-graft to preserve renal artery flow and percutaneous treatment of bilateral iliac and aortic aneurysm with two bifurcated stent-grafts. He was one of the early adaptors of thoracic Type B Dissection Treatment with Stent-Grafts as part of UVA vascular intervention team led by Dr Dake. His next appointment was Moffitt Cancer Center. Dr. Arslan initiated the radioembolization program at Moffitt. In 2011, 256 radioembolizations were performed which was the highest number of cases in the world. He then moved to Rush University Medical Center in Jan 2012, as the director of vascular/interventional radiology. He started developing both interventional oncology and peripheral vascular and aortic intervention programs at Rush. Radioembolization volume increased 10 folds and critical limb ischemia intervention volume increased 5 folds in the first two years of his tenure at Rush. Almost 1000 CLI interventions performed with 98% technical success rate. He also treats thoraco-abdominal aneurysms with percutaneous approach using Octopus technique. Dr Arslan performed the first ever percutaneous femoral to femoral vein bypass graft procedure to alleviate severe lower extremity swelling with excellent clinical outcome. He also performed the first ever percutaneous ilio-femoral arterial bypass procedure. An active researcher, Dr. Arslan has participated in more than 30 clinical trials and has authored more than 100 peer-reviewed articles and abstracts, as well as several book chapters.
Bulent Arslan, M.D., earned his medical degree at Marmara University in Istanbul, Turkey. He completed a residency in diagnostic radiology and a fellowship in vascular and interventional radiology at University of Rochester Medical Center, NY. Before joining Rush in 2012, he served as Associate Professor of Radiology & Interdisciplinary Oncology at University of South Florida College of Medicine, Tampa. Previously, he served as Assistant Professor of Radiology at University of Virginia Health System, Charlottesville, and at University of Arizona, Tucson. He recently obtained his professorship in Diagnostic Radiology and Nuclear Medicine at Rush University Medical Center Dr Arslan is certified by the ABR in Diagnostic Radiology with CAQ in Vascular & Interventional Radiology. His clinical interests include aortic and peripheral vascular interventions, endovascular treatment of complex abdominal, thoracic, thoracoabdominal and arch pathologies and endovascular tibio-pedal recanalization procedures for critical limb ischemia. An active researcher, Dr. Arslan has participated in more than 20 clinical trials and has authored more than 120 peer-reviewed articles and abstracts, as well as several book chapters. A frequent speaker, he has been an invited lecturer at more than 150 regional, national, and international medical conferences. Dr. Arslan is a fellow of SIR and a member of ARRS, RSNA, CIRSE, NANETS, ISNVD, and AMA. He currently serves as a reviewer for the Journal of Vascular and Interventional Radiology, CardioVascular and Interventional Radiology, and Neurosurgery.
Dr. Horacio Asbun is a general surgeon in Kendall, Florida. He received his medical degree from University of Chile and has been in practice for more than 20 years. Dr. Asbun accepts several types of health insurance, listed below.
Angie Amaro PA-C has been in the field of Intervention Radiology for the last 5 years and is the Chief Physician Assistant of Interventional and Vascular Radiology at Miami Cardiac and Vascular Institute.
I am a Thoracic Medical Oncologist at the Miami Cancer Institute. Board Certified. Member of ASCO and IASLC. Have a special intrest in the treatment of lung cancer.
Board-certified medical oncologist who treats patients with gastrointestinal cancers. Specializing in primary liver cancer (hepatocellular carcinoma), pancreas, gallbladder, and bile duct tumors. As part of a multidisciplinary group, my colleagues and I offer patients a team approach to treating these cancers.
Govindarajan Narayanan, M.D., is an interventional radiologist at the Miami Cardiac & Vascular Institute and the Chief of Interventional Oncology at the Miami Cancer Institute, part of Baptist Health South Florida. He is Board certified in diagnostic radiology and holds a Certificate of Added Qualification in interventional radiology.
Dr. Narayanan received his medical training at Madras Medical College in India. He completed a residency in Nuclear medicine at Methodist Hospital of Brooklyn and Memorial Sloan Kettering Cancer Center in New York, as well as a residency in Diagnostic Radiology at St. Barnabas Medical Center in Livingston, New Jersey. He also completed fellowships in Interventional radiology at Medical University of South Carolina in Charleston and Stony Brook University Hospital in New York.
Most recently, he served as the Chief of Interventional Radiology at University of Miami and Jackson Memorial hospital, and as the founding Chairman of the Department of Interventional Radiology at the University of Miami Miller School Of Medicine, where he also served as a Professor of Interventional Radiology.
Dr. Narayanan’s primary clinical research interests include pancreatic, liver and colon cancer. A member of numerous professional and honorary organizations, he is also a pioneer in his field, developing the technique of percutaneous irreversible electroporation (IRE) of the pancreas. He is widely published in high-impact medical journals as Cancer, Journal of Vascular and Interventional Radiology and Cardiovascular and Interventional Radiology and serves as a reviewer and editor for several scientific publications. He has authored textbook chapters and is an invited faculty member and speaker at several national and international scientific meetings.
Riccardo Lencioni, MD, FSIR, EBIR, is Professor of Radiology at the University of Pisa School of Medicine in Pisa, Italy, and Honorary Research Professor of Interventional Oncology at the Miami Cancer Institute in Miami, USA. He was previously Professor of Radiology and Director of Interventional Oncology Research at the University of Miami School of Medicine. Professor Lencioni is one of the world’s foremost interventional oncology specialists, known especially for his highly influential work in liver cancer. He has been the principal investigator of several large, multicenter, randomized clinical trials investigating the use of image-guided interventions for the treatment of hepatocellular carcinoma and the potential synergies between loco-regional therapies and systemic agents. Professor Lencioni has been a leading member of several expert panels developing recommendations for research and clinical management of hepatocellular carcinoma.
He is also known for having developed modified RECIST criteria for the assessment of tumor response in hepatocellular carcinoma. Riccardo Lencioni has been the Founding Chairman of the European Conference of Interventional Oncology, a co-Founder and Chairman of the World Conference of Interventional Oncology, and a Founding Governing Board Member and Executive Secretary of the International Liver Cancer Association. Riccardo Lencioni has published 206 articles in peer-reviewed international journals indexed in PubMed and numerous chapters in textbooks of interventional radiology, gastroenterology, oncology and surgery. In addition, he has been the editor of nine books. According to the SCOPUS database, citations of his publications currently number in excess of 21,000, for an h-index of 60. Riccardo Lencioni has received numerous international awards for his research and has been an invited or honorary lecturer at more than 500 international meetings or conferences held in 65 different countries.